LCN2 and breast cancer: Moreover, cytokines, such as IL-17 and TNF-a, activate transcription of LCN2, and stroma-derived LCN2 enhances the malignant phenotype of breast cancer cells and promotes cell metastasis, possibly by interacting with MMP-9 [80].